Kravarioti Dionysia, Chaito Hassan, Ouardouz Souhail, Al-Saab Elaf Abdulnaser, Wojtara Magda, Uwishema Olivier
Department of Research and Education Oli Health Magazine Organization Kigali Rwanda.
Department of Medicine Democritus University of Thrace Alexandroupolis Greece.
Health Sci Rep. 2025 Mar 5;8(3):e70536. doi: 10.1002/hsr2.70536. eCollection 2025 Mar.
Coronary artery disease (CAD), a leading cause of death globally, is among the most commonly diagnosed manifestations of heart disease. Although invasive coronary angiography (ICA) remains the "gold standard" to detect CAD, it is accompanied by several limitations. This review aims to present recent Noninvasive diagnostic modalities in CAD, report and compare the diagnostic accuracy of different invasive and noninvasive tests in CAD, and analyze both the current and future clinical implications of noninvasive modalities that regularly evaluate CAD in modern cardiology.
Given this background and purpose, various, reliable online sources were searched to find relevant data for our narrative review. To this end, several databases were consulted including Google Scholar, PubMed, and Embase.
The weight of the evidence highlights that the accuracy of several noninvasive diagnostic modalities in CAD is high and the choice of the most suitable noninvasive diagnostic testing mainly depends on local resources, tests' features, and patients' characteristics, which determine the pretest probability of CAD. For patients presenting an intermediate pretest probability of the disease noninvasive testing seems to be appropriate.
Noninvasive diagnostic modalities could limit the usage of invasive modalities in CAD. Nowadays, noninvasive diagnostic modalities are increasingly being promoted as they provide useful and reliable information about the various aspects of CAD. Undoubtedly, more efforts are needed to optimize noninvasive diagnostic tests to demonstrate their full potential in CAD.
冠状动脉疾病(CAD)是全球主要的死亡原因之一,是心脏病最常见的诊断表现之一。尽管有创冠状动脉造影(ICA)仍然是检测CAD的“金标准”,但其存在一些局限性。本综述旨在介绍CAD的最新无创诊断方法,报告并比较不同有创和无创检测在CAD中的诊断准确性,并分析现代心脏病学中定期评估CAD的无创方法的当前和未来临床意义。
鉴于此背景和目的,搜索了各种可靠的在线资源以获取我们叙述性综述的相关数据。为此,查阅了几个数据库,包括谷歌学术、PubMed和Embase。
证据的权重突出表明,几种CAD无创诊断方法的准确性很高,最合适的无创诊断测试的选择主要取决于当地资源、测试特征和患者特征,这些因素决定了CAD的预测试概率。对于疾病预测试概率为中等的患者,无创检测似乎是合适的。
无创诊断方法可以限制CAD中有创方法的使用。如今,无创诊断方法越来越受到推广,因为它们能提供有关CAD各个方面的有用且可靠的信息。毫无疑问,需要做出更多努力来优化无创诊断测试,以充分发挥其在CAD中的潜力。